204 related articles for article (PubMed ID: 27737899)
1. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.
Li L; Qi X; Sun W; Abdel-Azim H; Lou S; Zhu H; Prasadarao NV; Zhou A; Shimada H; Shudo K; Kim YM; Khazal S; He Q; Warburton D; Wu L
EMBO Mol Med; 2016 Nov; 8(11):1340-1359. PubMed ID: 27737899
[TBL] [Abstract][Full Text] [Related]
2. Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
Abdel-Azim H; Sun W; Wu L
Pharmacol Ther; 2019 Dec; 204():107403. PubMed ID: 31470030
[TBL] [Abstract][Full Text] [Related]
3. Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.
Ding W; Shimada H; Li L; Mittal R; Zhang X; Shudo K; He Q; Prasadarao NV; Wu L
Blood; 2013 Feb; 121(6):996-1007. PubMed ID: 23243275
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin a contributed to CCIN treatment by promoting neutrophil bactericidal activity via activation CBL-dependent ERK pathway.
Qi X; Liu J; Li X; Fan M; Huang N; Sun R
Phytomedicine; 2021 Feb; 82():153444. PubMed ID: 33421903
[TBL] [Abstract][Full Text] [Related]
5. Saikosaponin d contributed to cancer chemotherapy induced neutropenia therapy by promoting neutrophil differentiation via activation CBL-dependent ERK pathway.
Qi X; Fan M; Huang N; Zhang X; Liu J; Li X; Sun R
Pharmacol Res; 2020 Oct; 160():105149. PubMed ID: 32822868
[TBL] [Abstract][Full Text] [Related]
6. Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation.
Miyabe C; Miyabe Y; Miura NN; Takahashi K; Terashima Y; Toda E; Honda F; Morio T; Yamagata N; Ohno N; Shudo K; Suzuki J; Isobe M; Matsushima K; Tsuboi R; Miyasaka N; Nanki T
Arthritis Rheum; 2013 Feb; 65(2):503-12. PubMed ID: 23203767
[TBL] [Abstract][Full Text] [Related]
7. Differential phenotype of immune cells in blood and milk following pegylated granulocyte colony-stimulating factor therapy during a chronic Staphylococcus aureus infection in lactating Holsteins.
Putz EJ; Eder JM; Reinhardt TA; Sacco RE; Casas E; Lippolis JD
J Dairy Sci; 2019 Oct; 102(10):9268-9284. PubMed ID: 31400902
[TBL] [Abstract][Full Text] [Related]
8. Effect of neutropenia and granulocyte colony stimulating factor-induced neutrophilia on blood-brain barrier permeability and brain edema after traumatic brain injury in rats.
Whalen MJ; Carlos TM; Wisniewski SR; Clark RS; Mellick JA; Marion DW; Kochanek PM
Crit Care Med; 2000 Nov; 28(11):3710-7. PubMed ID: 11098978
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
[TBL] [Abstract][Full Text] [Related]
10. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
[TBL] [Abstract][Full Text] [Related]
11. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary administration of Am80 regenerates collapsed alveoli.
Sakai H; Horiguchi M; Ozawa C; Akita T; Hirota K; Shudo K; Terada H; Makino K; Kubo H; Yamashita C
J Control Release; 2014 Dec; 196():154-60. PubMed ID: 25312542
[TBL] [Abstract][Full Text] [Related]
13. Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line.
Shiohira H; Kitaoka A; Shirasawa H; Enjoji M; Nakashima M
Int J Mol Med; 2010 Sep; 26(3):393-9. PubMed ID: 20664956
[TBL] [Abstract][Full Text] [Related]
14. A GCSFR/CSF3R zebrafish mutant models the persistent basal neutrophil deficiency of severe congenital neutropenia.
Pazhakh V; Clark S; Keightley MC; Lieschke GJ
Sci Rep; 2017 Mar; 7():44455. PubMed ID: 28281657
[TBL] [Abstract][Full Text] [Related]
15. Gcsf-Chr19 promotes neutrophil migration to damaged tissue through blood vessels in zebrafish.
Galdames JA; Zuñiga-Traslaviña C; Reyes AE; Feijóo CG
J Immunol; 2014 Jul; 193(1):372-8. PubMed ID: 24890728
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
17. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
18. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5.
Fujiu K; Manabe I; Ishihara A; Oishi Y; Iwata H; Nishimura G; Shindo T; Maemura K; Kagechika H; Shudo K; Nagai R
Circ Res; 2005 Nov; 97(11):1132-41. PubMed ID: 16224062
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil dynamics in response to chemotherapy and G-CSF.
Zhuge C; Lei J; Mackey MC
J Theor Biol; 2012 Jan; 293():111-20. PubMed ID: 22037060
[TBL] [Abstract][Full Text] [Related]
20. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
Dror Y; Ward AC; Touw IP; Freedman MH
Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
